China Is Full of Risk For U.S. Companies

For decades, America’s corporate chieftains saw China as a money spinner. They gushed about its hundreds of millions of consumers, called it “one of the biggest opportunities” and made predictions that this would be “China’s century.” Now, those executives have come away from recent visits to the country with a more sober view. Western companies doing business in China are facing pressures that were unimaginable several years ago. The country’s economy is floundering and its relationship with the United States is strained. Three years of border restrictions and an effective…

Hunting for the next virus

Searching for the next virus The Covid-19 pandemic is not over yet, but some researchers are already worrying about mousepox. Colin Carlson, a biologist at Georgetown University, has spent the last few years training computers to predict which dangerous viruses could jump from animals to humans, following in the footsteps of the coronavirus (which came from bats), H.I.V. (chimpanzees) and hundreds of other pathogens. His team used machine learning to develop a short list of potentially dangerous viruses that could eventually make a leap. Mousepox — a virus that infects…

Most of the World’s Vaccines Likely Won’t Prevent Infection From Omicron

A growing body of preliminary research suggests the Covid vaccines used in most of the world offer almost no defense against becoming infected by the highly contagious Omicron variant. All vaccines still seem to provide a significant degree of protection against serious illness from Omicron, which is the most crucial goal. But only the Pfizer and Moderna shots, when reinforced by a booster, appear to have initial success at stopping infections, and these vaccines are unavailable in most of the world. The other shots — including those from AstraZeneca, Johnson…

Most of the World’s Vaccines Likely Won’t Prevent Infection From Omicron

A growing body of preliminary research suggests the Covid vaccines used in most of the world offer almost no defense against becoming infected by the highly contagious Omicron variant. All vaccines still seem to provide a significant degree of protection against serious illness from Omicron, which is the most crucial goal. But only the Pfizer and Moderna shots, when reinforced by a booster, appear to have initial success at stopping infections, and these vaccines are unavailable in most of the world. The other shots — including those from AstraZeneca, Johnson…